$0.61
-0.1001[-14.10%]
Last update: 9:43AM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$0.70
0.0900[14.75%]
| Open0.728 | Close- |
| Vol / Avg.76.664K / 312.651K | Mkt Cap1.912M |
| Day Range0.630 - 0.700 | 52 Wk Range0.574 - 33.900 |
Bone Biologics Stock (NASDAQ:BBLG), Key Statistics
Bone Biologics Stock (NASDAQ: BBLG) analysis, key statistics.
Valuation Measures
Enterprise Value
15M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.39
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1505.14%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.82
Tangible Book value per share
1.82
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLG), Key Statistics
Bone Biologics Stock (NASDAQ: BBLG) analysis, key statistics.
Valuation Measures
Enterprise Value
15M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.39
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1505.14%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.82
Tangible Book value per share
1.82
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLG), Key Statistics
Bone Biologics Stock (NASDAQ: BBLG) analysis, key statistics.
Valuation Measures
Enterprise Value
15M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.39
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1505.14%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.82
Tangible Book value per share
1.82
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLG), Key Statistics
Bone Biologics Stock (NASDAQ: BBLG) analysis, key statistics.
Valuation Measures
Enterprise Value
15M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.39
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1505.14%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.82
Tangible Book value per share
1.82
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLG), Key Statistics
Bone Biologics Stock (NASDAQ: BBLG) analysis, key statistics.
Valuation Measures
Enterprise Value
15M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.39
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1505.14%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.82
Tangible Book value per share
1.82
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLG), Key Statistics
Bone Biologics Stock (NASDAQ: BBLG) analysis, key statistics.
Valuation Measures
Enterprise Value
15M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.39
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1505.14%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.82
Tangible Book value per share
1.82
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLG), Key Statistics
Bone Biologics Stock (NASDAQ: BBLG) analysis, key statistics.
Valuation Measures
Enterprise Value
15M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.39
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1505.14%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.82
Tangible Book value per share
1.82
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLG), Key Statistics
Bone Biologics Stock (NASDAQ: BBLG) analysis, key statistics.
Valuation Measures
Enterprise Value
15M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.39
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1505.14%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.82
Tangible Book value per share
1.82
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Bone Biologics Stock (NASDAQ:BBLG), Key Statistics
Bone Biologics Stock (NASDAQ: BBLG) analysis, key statistics.
Valuation Measures
Enterprise Value
15M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.39
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-1505.14%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
1.82
Tangible Book value per share
1.82
Total Liabilities (Quarterly)
1.9M
Total Assets
7.6M
Total Liabilities
1.9M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -